WallStreetZenWallStreetZen

NASDAQ: ONCT
Oncternal Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ONCT

Based on 3 analysts offering 12 month price targets for Oncternal Therapeutics Inc.
Min Forecast
$26.00+159.22%
Avg Forecast
$32.00+219.04%
Max Forecast
$40.00+298.8%

Should I buy or sell ONCT stock?

Based on 3 analysts offering ratings for Oncternal Therapeutics Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ONCT stock forecasts and price targets.

ONCT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-29
lockedlocked$00.00+00.00%2023-12-04
lockedlocked$00.00+00.00%2023-09-07

1 of 1

Forecast return on equity

Is ONCT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.96%

Forecast return on assets

Is ONCT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ONCT revenue forecast

What is ONCT's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$675.0k+2.43%
Avg 2 year Forecast
$750.0k+13.81%
Avg 3 year Forecast
$750.0k+13.81%
ONCT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ONCT revenue growth forecast

How is ONCT forecast to perform vs Biotechnology companies and vs the US market?
Company
5.03%
Industry
45.76%
Market
10.79%
ONCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ONCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ONCT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ONCT$10.03$32.00+219.04%Buy
APRE$8.00$20.00+150.00%Buy
ICU$0.79N/AN/A
RGLS$1.49$10.50+604.70%Strong Buy
NRBO$6.24N/AN/A

Oncternal Therapeutics Stock Forecast FAQ

Is Oncternal Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ONCT) stock is to Buy ONCT stock.

Out of 3 analysts, 1 (33.33%) are recommending ONCT as a Strong Buy, 1 (33.33%) are recommending ONCT as a Buy, 1 (33.33%) are recommending ONCT as a Hold, 0 (0%) are recommending ONCT as a Sell, and 0 (0%) are recommending ONCT as a Strong Sell.

If you're new to stock investing, here's how to buy Oncternal Therapeutics stock.

What is ONCT's revenue growth forecast for 2024-2026?

(NASDAQ: ONCT) Oncternal Therapeutics's forecast annual revenue growth rate of 5.03% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.79%.

Oncternal Therapeutics's revenue in 2024 is $659,000.On average, 2 Wall Street analysts forecast ONCT's revenue for 2024 to be $1,990,200, with the lowest ONCT revenue forecast at $1,769,067, and the highest ONCT revenue forecast at $2,211,334. On average, 1 Wall Street analysts forecast ONCT's revenue for 2025 to be $2,211,334, with the lowest ONCT revenue forecast at $2,211,334, and the highest ONCT revenue forecast at $2,211,334.

In 2026, ONCT is forecast to generate $2,211,334 in revenue, with the lowest revenue forecast at $2,211,334 and the highest revenue forecast at $2,211,334.

What is ONCT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ONCT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ONCT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ONCT price target, the average ONCT price target is $32.00, with the highest ONCT stock price forecast at $40.00 and the lowest ONCT stock price forecast at $26.00.

On average, Wall Street analysts predict that Oncternal Therapeutics's share price could reach $32.00 by Jan 29, 2025. The average Oncternal Therapeutics stock price prediction forecasts a potential upside of 219.04% from the current ONCT share price of $10.03.

What is ONCT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ONCT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.